Item | Property | Value | Comments |
---|
include | http://hl7.org/fhir/sid/cvx | | |
Concept | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose | |
Concept | 208 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose | |
Concept | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | |
Concept | 211 | COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL | |
Concept | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | |
Concept | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | |
Concept | 217 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose | |
Concept | 218 | COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose | |
Concept | 219 | COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose | |
Concept | 221 | COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose | |
Concept | 225 | COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL | |
Concept | 226 | COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL | |
Concept | 227 | COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose | |
Concept | 228 | COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose | |
Concept | 229 | COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose | |
Concept | 230 | COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL | |
Concept | 300 | COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose | |
Concept | 301 | COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose | |
Concept | 302 | COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose | |
Concept | 500 | COVID-19 Non-US Vaccine, Product Unknown | |
Concept | 501 | COVID-19 IV Non-US Vaccine (QAZCOVID-IN) | |
Concept | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | |
Concept | 503 | COVID-19 LAV Non-US Vaccine (COVIVAC) | |
Concept | 504 | COVID-19 VVnr Non-US Vaccine (Sputnik Light) | |
Concept | 505 | COVID-19 VVnr Non-US Vaccine (Sputnik V) | |
Concept | 506 | COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology) | |
Concept | 507 | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) | |
Concept | 508 | COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) | |
Concept | 509 | COVID-19 PS Non-US Vaccine (EpiVacCorona) | |
Concept | 510 | COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) | |
Concept | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | |
Concept | 512 | SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) | |
Concept | 513 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) | |
Concept | 514 | SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) | |
Concept | 515 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) | |
Concept | 516 | COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) | |
Concept | 517 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) | |
Concept | 518 | COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) | |
Concept | 519 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna | |
Concept | 520 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech | |